insulin infusion set (IIS) blockage, infusion site problems, insulin stability issues, user error, or a combination of these. Users are therefore exposed to significant and potentially fatal ...

She receives the treatments every two weeks, with her sixth infusion set for mid-August. Lieb is among the initial group of about a dozen patients at Independence’s Greensburg and Butler ...

The FDA has approved a prefilled syringe formulation of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) that allows patients to self-inject the medication.